New York, Dec 5 (Ians) Researchers have discovered that the treatment of Sars-CoV-2 infection (Covid-19) with a new antiviral drug, Mk-4482/Eidd-2801 or Molnupiravir, completely suppresses the virus transmission within 24 hours.
According to the study, published in the journal Nature Microbiology, the research team from Georgia State University (Gsu) originally discovered that the drug is potent against influenza viruses.
"This is the first demonstration of an orally available drug to rapidly block Sars-CoV-2 transmission. Mk-4482/Eidd-2801 could be game-changing," said study author Richard Plemper from Gsu.
Because the drug can be taken by mouth, treatment can be started early for a potentially three-fold benefit: inhibit patients' progress to severe disease, shorten the infectious phase to ease the emotional and socio-economic toll of prolonged patient isolation and rapidly silence local outbreaks,
"We noted early on that Mk-4482/Eidd-2801 has broad-spectrum activity against respiratory Rna viruses and that treating infected animals by mouth...
According to the study, published in the journal Nature Microbiology, the research team from Georgia State University (Gsu) originally discovered that the drug is potent against influenza viruses.
"This is the first demonstration of an orally available drug to rapidly block Sars-CoV-2 transmission. Mk-4482/Eidd-2801 could be game-changing," said study author Richard Plemper from Gsu.
Because the drug can be taken by mouth, treatment can be started early for a potentially three-fold benefit: inhibit patients' progress to severe disease, shorten the infectious phase to ease the emotional and socio-economic toll of prolonged patient isolation and rapidly silence local outbreaks,
"We noted early on that Mk-4482/Eidd-2801 has broad-spectrum activity against respiratory Rna viruses and that treating infected animals by mouth...
- 12/5/2020
- by IANS
- GlamSham
New York, Dec 5 (Ians) Researchers have discovered that the treatment of Sars-CoV-2 infection (Covid-19) with a new antiviral drug, Mk-4482/Eidd-2801 or Molnupiravir, completely suppresses the virus transmission within 24 hours.
According to the study, published in the journal Nature Microbiology, the research team from Georgia State University (Gsu) originally discovered that the drug is potent against influenza viruses.
"This is the first demonstration of an orally available drug to rapidly block Sars-CoV-2 transmission. Mk-4482/Eidd-2801 could be game-changing," said study author Richard Plemper from Gsu.
Because the drug can be taken by mouth, treatment can be started early for a potentially three-fold benefit: inhibit patients' progress to severe disease, shorten the infectious phase to ease the emotional and socio-economic toll of prolonged patient isolation and rapidly silence local outbreaks,
"We noted early on that Mk-4482/Eidd-2801 has broad-spectrum activity against respiratory Rna viruses and that treating infected animals by mouth...
According to the study, published in the journal Nature Microbiology, the research team from Georgia State University (Gsu) originally discovered that the drug is potent against influenza viruses.
"This is the first demonstration of an orally available drug to rapidly block Sars-CoV-2 transmission. Mk-4482/Eidd-2801 could be game-changing," said study author Richard Plemper from Gsu.
Because the drug can be taken by mouth, treatment can be started early for a potentially three-fold benefit: inhibit patients' progress to severe disease, shorten the infectious phase to ease the emotional and socio-economic toll of prolonged patient isolation and rapidly silence local outbreaks,
"We noted early on that Mk-4482/Eidd-2801 has broad-spectrum activity against respiratory Rna viruses and that treating infected animals by mouth...
- 12/5/2020
- by IANS
- GlamSham
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, and blog posts do not represent IMDb's opinions nor can we guarantee that the reporting therein is completely factual. Please visit the source responsible for the item in question to report any concerns you may have regarding content or accuracy.